News | October 31, 2011

New Report Shows Advances in Combat Casualty Care for Vascular Injuries

October 31, 2011 — A panel presentation at the American College of Surgeons' annual clinical congress detailed how the contemporary practice of vascular surgery has evolved during the Iraq and Afghanistan wars. This has resulted in superior outcomes for complex, combat-related vascular injuries, including increased rates of amputation-free survival following extremity wounds.

The presentation, titled "Update on Wartime Vascular Injury and The Joint Theater Trauma Registry," was given by Lt. Col. Charles J. Fox, M.D., F.A.C.S., associate professor and past program director of vascular surgery at Walter Reed National Military Medical Center. It provided an overview of 10 years of vascular surgery advances in the current conflicts.

The presentation also highlighted the important role of the Joint Theater Trauma Registry (JTTR), a data collection tool created in 2004 as part of the Joint Theater Trauma System. The JTTR supports evidence-based improvements in battlefield trauma care, reduction of morbidity and mortality, and analysis of injury patterns, clinical decision-making and outcomes.

"Innovations in combat casualty care continue to advance the practice of both military and civilian vascular surgery," said Fox. "An important component is a multidisciplinary, team approach to treating patients with complex injuries."

Key innovations in caring for combat-related vascular injuries from the last decade include:


  • Joint Theater Trauma System. This theater-wide trauma system was established in conjunction with the U.S. Army Institute of Surgical Research and the American College of Surgeons Committee on Trauma. It led to deployment of forward surgical teams with Level III capabilities much closer to soldiers in the field. Surgeons now definitively repair all recognized vascular injuries before soldiers leave Iraq or Afghanistan. Fast evacuation is possible with a median time of approximately 8.5 days from the point of vascular injury in theater to arrival in a United States level V facility. Weekly teleconferences across three continents take place to discuss ongoing management of vascular injuries; in addition, Web-based electronic medical records that follow soldiers back home, ensuring continuity of care.


  • Widespread use of tourniquets. In a reversal of previous medical practice, the military now widely distributes tourniquets and trains soldiers and medics in their use. Most combat-related extremity injuries now arrive with tourniquets applied pre-hospital; the practice is widely credited with saving the lives of soldiers who might have died on the battlefield in previous conflicts due to hemorrhage.


  • Advances in damage control resuscitation (DCR). DCR techniques, such as rapid transfusion of fresh, warm blood components and treating hypothermia upon admission to battlefield hospitals, enable vascular surgeons to perform more procedures in forward deployed (Level III) surgical sites closer to the fight; this avoids delaying treatment waiting to evacuate patients to higher-level trauma hospitals. Modern DCR practices helped reduce case fatality rates to 9.4 percent in the current conflicts compared to 19.1 percent in World War II and 15.8 percent in Vietnam.


  • Temporary vascular shunts. These devices give military surgeons additional time to address more life-threatening injuries, assess treatment options and, if needed, evacuate soldiers from battlefield hospitals.


The U.S. Army continues to examine clinical outcomes and JTTR data in its quest to enhance battlefield care. Fox described areas for future research and emerging endovascular therapies to further improve the diagnosis and treatment of combat-related vascular injuries. For example, the availability of advanced diagnostic imaging equipment, such as CT scanners, as well as modern catheters and stents, increases the variety and complexity of endovascular interventions possible at Level III battlefield hospitals.

These less-invasive technologies also allow surgeons to find and address hidden vascular injuries that may otherwise have gone unnoticed for weeks.

The Army has also promoted the widespread use of closed negative pressure wound therapy. The technique enables surgeons to close deep soft tissue wounds, typically caused by explosions, to ensure vessel grafts remain covered with healthy muscle tissue. This emerging therapy is improving surgeons' ability to close large cavity wounds that previously would have required amputation.

Graft surveillance provides useful clinical data to generate modern guidelines for emergent limb reconstruction in the repair of combat-related vascular injuries. An ultrasound offers a less invasive alternative to angiography and catheter-based arteriograms that are usually performed at the time of injury or shortly after evacuation.

Vascular injuries comprise up to nine percent of combat-related injuries sustained in Iraq and Afghanistan, triple the rate during Vietnam; extremity injuries account for 75 percent of all vascular injuries in the current conflicts. Analysis of vascular injury patterns, vessel repair methods and patient outcomes based on JTTR data led to improvements in soldier training, equipment and combat casualty care over the last decade. This has allowed a greater percentage of soldiers suffering vascular trauma to survive long enough to reach medical care.

The panel presentation was based on the article, "Update on Wartime Vascular Injury," by Lt. Col. Fox, Bhavin Patel, B.S., and Lt. Col. W. Darrin Clouse, M.D., F.A.C.S., published in the March 2011 issue of the journal Perspectives in Vascular Surgery and Endovascular Therapy.

For more information: www.healthcare.goarmy.com

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init